Aravive (STU:VE11) Other Long Term Assets : €2.26 Mil (As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Aravive Other Long Term Assets?

Aravive's other long-term assets for the quarter that ended in Sep. 2023 was €2.26 Mil.

Aravive's quarterly other long-term assets declined from Mar. 2023 (€2.30 Mil) to Jun. 2023 (€2.21 Mil) but then increased from Jun. 2023 (€2.21 Mil) to Sep. 2023 (€2.26 Mil).

Aravive's annual other long-term assets increased from Dec. 2020 (€2.01 Mil) to Dec. 2021 (€2.16 Mil) and increased from Dec. 2021 (€2.16 Mil) to Dec. 2022 (€2.31 Mil).

Aravive Other Long Term Assets Historical Data

The historical data trend for Aravive's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aravive Other Long Term Assets Chart

Aravive Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Long Term Assets

Get a 7-Day Free Trial

2.12

2.87

2.01

2.16

2.31

Aravive Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Other Long Term Assets	Get a 7-Day Free Trial															2.47	2.31	2.30	2.21	2.26

Aravive Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Aravive (STU:VE11) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aravive Inc (STU:VE11) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

ARAV:USA VE11:Germany

Address

3730 Kirby Drive, River Oaks Tower, Suite 1200, Houston, TX, USA, 77098

Website

https://www.aravive.com

Aravive Inc is a clinical-stage biopharmaceutical company. It focuses on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. The company pipeline product Batiraxcept (formerly AVB-500) which is an ultra-high affinity decoy protein that binds to GAS6 and thereby prevents AXL signaling to inhibit metastasis and tumor growth and restore sensitivity to anti-cancer agents. Batiraxcept is currently being evaluated in multiple clinical trials.

Aravive (STU:VE11) Headlines

No Headlines